As of this posting, the U.S. House of Representatives and Senate are not close to agreement on an appropriations bill that would fund the Department of Health and Human Services, the National Institutes of Health (NIH), and other federal health agencies for fiscal year 2026, which begins on October 1. Consequently, a partial federal government shutdown...
September Will Be Critical Legislative Month in Congress; Endocrine Society Advocates for Policy Priorities When the Congress returned to Washington, D.C., September 2 from its six-week recess, it will have only 28 days to pass legislation to fund the federal government or face a government shutdown. The federal fiscal year ends September 30, and by...
CMS Releases Proposed Physician Payment Rule for 2026; New Policies Expected to Provide 3% Increase for Endocrinology The Centers for Medicare and Medicaid Services (CMS) released the annual Medicare Physician Fee Schedule (MPFS) proposed rule for calendar year 2026. This rule updates payment policies and payment rates for Part B services furnished under the MPFS,...
Administration Moves Forward with NIH Funding Cuts, Restructuring On Friday, May 2, the White House released the president’s budget request for Fiscal Year 2026 (FY26). As is typical in the first year of a presidential term, the budget lacks many details, and so it is informally referred to as a “skinny budget.” The budget outlines... Endocrine Society is Advocating for You We know this has been an extraordinary turbulent and disruptive time for U.S. researchers and our colleagues around the world. Since January, there have been a myriad of U.S. executive actions affecting researchers, including cuts to research, firing of federal workers, rescinded grants, and withdrawn funding opportunities. In early...
Endocrine Society Advocates to Protect Funding for NIH and Reauthorize SDP on Capitol Hill On Wednesday, March 12, the Endocrine Society hosted a Researcher Hill Day and brought members from across the country to Washington, D.C., to meet with their senators and representatives and discuss the importance of completing the appropriations process for Fiscal Year...
A monthly wrap-up of the Endocrine Society’s Advocacy efforts on behalf of the practice and science of endocrinology in the U.S. and around the world. Short-term Extension of SDP and Telehealth Waivers Signed into Law On December 21, 2024, President Biden signed into law a slimmed-down, temporary government spending bill to avoid a government shutdown....
Congress Returns to Washington for “Lame Duck” Session and to Complete Work for 2024 Following the November elections, Congress will return to Washington, D.C., to complete work on federal funding and a package of several pieces of health legislation including many priorities of the Endocrine Society. Federal funding for the government expires December 20, 2024,...
